MedTrace Logo

Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials

NCT05886764 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2026-04-27

No results posted yet for this study

Summary

This trial will study different outreach methods to assess impact on enrollment of underrepresented minorities (specifically African Americans) to early phase cancer clinical treatment trials. Both patients and providers (those seeing enrolled patients) will be enrolled and receive the study interventions or no intervention (control arm).

Conditions

  • Cancer
  • Malignancy
  • Malignant Neoplasm

Interventions

OTHER

Digital Intervention

Digital messages (email, text, etc.) which include general educational information about clinical trials and available resources.

OTHER

Community Outreach

Invitation to contact a Community Ambassador for further information and support in the decision to participate in a clinical trial.

Sponsors & Collaborators

  • Stand Up To Cancer

    collaborator OTHER

  • University of Chicago

    lead OTHER

Principal Investigators

  • Briseis Aschebrook-Kilfoy · University of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-23
Primary Completion
2026-02-26
Completion
2028-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05886764 on ClinicalTrials.gov